TITLE

COMMENTARY: Review: Thiazolidinediones increase risk for heart failure in type 2 diabetes

AUTHOR(S)
Byrne, Christopher D.
PUB. DATE
January 2008
SOURCE
ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p5
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author comments on the meta- analysis concerning the association of thiazolidinediones for heart failures in patients with non-insulin-dependent diabetes. He asserts that the study is useful for practicing health care professionals due to the magnitude of risk is quantified. He pointed out that the study recommends changes to package inserts for thiazolidinedione drugs. He suggests to define the precise role of thiazolidinediones in the management of type 2 diabetes in further studies.
ACCESSION #
28694425

 

Related Articles

  • Review: Thiazolidinediones increase risk for heart failure in type 2 diabetes.  // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p5 

    The article presents a clinical study that evaluates the risk for heart failure associated with thiazolidinediones in patients with non-insulin-dependent diabetes. The evaluation was conducted on patients with diabetes and heart failure of more than six months. A meta-analysis revealed that the...

  • Prevalence, Incidence and Risk Factors of Chronic Heart Failure in the Type 2 Diabetic Population: Systematic Review. Linuo Zhou; Wei Deng; Lixue Zhou; Ping Fang; Daikun He; Weiwei Zhang; Kui Liu; Renming Hu // Current Diabetes Reviews;2009, Vol. 5 Issue 3, p171 

    Objectives: The aim of this review was to examine the prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population. Methods: A systematic search of studies related to chronic heart failure (CHF) in the diabetic population was performed using medical...

  • What is the best first-line therapy for type 2 diabetes? Price, Hermione; Cavan, David // Diabetes Digest;2015, Vol. 14 Issue 3, p146 

    The article offers the author's insights as multidisciplinary team members on the published paper regarding the comparative effectiveness patient-centered study on the initial choice for diabetes mellitus oral glucose-lowering treatment. Topics mentioned include the effectiveness of first-line...

  • Effects of Thiazolidinediones Beyond Glycaemic Control. Kalaitzidis, Rigas G.; Sarafidis, Pantelis A.; Bakris, George L. // Current Pharmaceutical Design;2/11/2009, Vol. 15 Issue 5, p529 

    The incidence of type 2 diabetes continues to increase in the western world over the past decade. Consequently, complications of this disease have reached crisis proportions. In addition to the classical oral hypoglycaemic agents, i.e. sulfonylureas, newer classes have emerged that work by...

  • Thiazolidinediones and Cardiovascular Risk -- A Question of Balance. Erdmann, Erland; Charbonnel, Bernard; Wilcox, Robert // Current Cardiology Reviews;2009, Vol. 5 Issue 3, p155 

    Background: Several recent meta-analyses of adverse event data from randomized controlled trials with rosiglitazone reveal a possible association between this thiazolidinedione and an increased risk of ischemic myocardial events. This has led to debate on the overall clinical benefit of...

  • in the clinic: Heart Failure. Goldberg, Lee R. // Annals of Internal Medicine;6/1/2010, Vol. 152 Issue 11, pITC6-1 

    The article focuses on the prevention, diagnosis, and treatment of heart failure. It discusses risk factors including hypertension and type 2 diabetes mellitus, medications for the prevention of heart failure, the symptoms of heart failure, treatment options and recommendations from professional...

  • Avandia, Risk of Congestive Heart Failure Significant Safety Risk.  // Clinical Oncology Alert;Jul2007, Vol. 23 Issue 7, p1 

    The article reports on the association of heart failure with rosiglitazone use. It states that the U.S. Food and Drug Administration (FDA) will give a black box warning to the drug which is used for treating type 2 diabetes. Based on a study conducted, there was no evidence of an increased death...

  • Antidiabetic Drugs and Heart Failure Risk in Patients With Type 2 Diabetes in the U.K. Primary Care Setting. Maru, Shoko; Koch, Gary G.; Stender, Monika; Clark, Douglas; Gibowski, Laura; Petri, Hans; White, Alice D.; Simpson JR., Ross J. // Diabetes Care;Jan2005, Vol. 28 Issue 1, p20 

    OBJECTIVE -- To assess the effects of antidiabetic drugs on the risk of heart failure in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS -- We conducted a retrospective cohort study with a newly diagnosed diabetes cohort of 25,690 patients registered in the U.K. General Practice...

  • Key Global Literature. Pendergrass, Merri // Diabetes Care;Dec2007, Vol. 30 Issue 12, p3152 

    The article highlights the findings of several studies on diabetes care. One study on the effect of multiple short-duration with single long-duration exercise sessions on glucose homeostatis in type 2 diabetes mellitus has found that multiple sessions of aerobic exercise were preferable among...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics